Rapid review finds molnupiravir, nirmatrelvir–ritonavir, and simnotrelvir–ritonavir increased recovery or reduced time to recovery with varying adverse event profiles, and molnupiravir could have long-term benefits for 3 to 6 months.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers evaluated perioperative and postdischarge factors associated with opioid refill prescriptions during the first 90 days after inpatient otolaryngology–head and neck surgery.